D-0025-2025 Class II Ongoing

Recalled by Akron Pharma, Inc. — Fairfield, NJ

FDA drug recall D-0025-2025 was initiated by Akron Pharma, Inc. on Oct 15, 2024 and is designated Class II. Reason for recall: CGMP Deviations The recall status is ongoing. Affected quantity: 10845 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 30, 2024
Initiation Date
Oct 15, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
10845 bottles

Product description

OneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool Softener Laxative, 16 FL OZ (473 mL) bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., Fairfield, NJ 07004, NDC 71399-0039-06.

Reason for recall

CGMP Deviations

Distribution pattern

Nationwide in the US

Code information

Lot #ODS230001A, ODS230002A, Exp. 10/2025; ODS230003A, Exp. 11/2025.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0025-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0025-2025. Report a data issue: hello@regdatalab.com.